Next Article in Journal
A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin
Next Article in Special Issue
Prognostic Value of the Hemoglobin/Red Cell Distribution Width Ratio in Resected Lung Adenocarcinoma
Previous Article in Journal
Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study
Editorial

Diagnosis and Treatment of Primary and Secondary Lung Cancers

1
Department of Thoracic Surgery, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy
2
Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, 20141 Milan, Italy
Cancers 2021, 13(3), 448; https://doi.org/10.3390/cancers13030448
Received: 20 January 2021 / Revised: 21 January 2021 / Accepted: 24 January 2021 / Published: 25 January 2021
(This article belongs to the Special Issue Diagnosis and Treatment of Primary and Secondary Lung Cancers)
Note: In lieu of an abstract, this is an excerpt from the first page.

Primary and secondary lung cancers are the most common clinical conditions that thoracic surgeons have to deal with: primary lung cancer, in fact, is one of the most frequently diagnosed cancers and is the leading cause of cancer-related death worldwide [...] View Full-Text
MDPI and ACS Style

Petrella, F. Diagnosis and Treatment of Primary and Secondary Lung Cancers. Cancers 2021, 13, 448. https://doi.org/10.3390/cancers13030448

AMA Style

Petrella F. Diagnosis and Treatment of Primary and Secondary Lung Cancers. Cancers. 2021; 13(3):448. https://doi.org/10.3390/cancers13030448

Chicago/Turabian Style

Petrella, Francesco. 2021. "Diagnosis and Treatment of Primary and Secondary Lung Cancers" Cancers 13, no. 3: 448. https://doi.org/10.3390/cancers13030448

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop